#RCSU_SciChalXI GENE EDITING
Crispr News
-
Research Roundup: 21 Genes Linked to Increased Risk of Alzheimer's and More - BioSpaceAugust 12, 2022
-
New drug candidate may fight off 200+ antibiotic-resistant bacteria - Medical News TodayAugust 12, 2022
-
Research Shows That Mucus Is Your Body’s First Line Of Defense Against Viruses - ForbesAugust 11, 2022
-
Genome Editing Terminology Is Standardized in NIST-Led Effort | NIST - NISTAugust 11, 2022
-
Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells - Nature.comAugust 11, 2022
-
CRISPR-Inspired Test Brings At-Home Diagnostics Closer to Reality - Medical Device and Diagnostics IndustryAugust 11, 2022
-
High cholesterol: New CRISPR treatment enters human trial - Medical News TodayAugust 10, 2022
-
Cure Rare Disease Scores IND for First-in-Human CRISPR Therapeutic - BioSpaceAugust 10, 2022
-
Improving crop resilience with nanoparticles - Nature.comAugust 10, 2022
-
Genome Editing Market to be Worth $19.4 Billion by 2028: Grand View Research, Inc. - BloombergAugust 10, 2022
-
Vir Biotechnology (NASDAQ:VIR) & CRISPR Therapeutics (NASDAQ:CRSP) Financial Survey - Defense WorldAugust 10, 2022
-
iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform - BioSpaceAugust 10, 2022
-
A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva - News-Medical.NetAugust 10, 2022
-
CRISPR-Cas9 gene editing can give rise to cell toxicity, genomic instability: study - The Science BoardAugust 9, 2022
-
A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples - Nature.comAugust 9, 2022
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.